761675

544742

SAIPARENT

img img img img
No Data Available

Sai Parenterals Ltd Share Price Update

As of the latest trading session, Sai Parenterals Ltd share price is currently at ₹447.6, which is up by ₹10.89 from its previous closing. Today, the stock has fluctuated between ₹439.15 and ₹454.00. Over the past year, Sai Parenterals Ltd has achieved a return of [-]%. In the last month alone, the return has been 5.16%.

Sai Parenterals Ltd performance

Today’s low

Today’s high

₹ 439.15 ₹ 454.00
₹ 439.85

52 week low

52 week high

₹ 400.00 ₹ 457.45
₹ 439.85

Open Price

₹ 444.00

Prev. Close

₹ 436.70

Volume (Shares)

343490.00

Total traded value

₹ 1510.84

Upper Circuit

₹ 524.00

Lower Circuit

₹ 349.40

info

Investment Returns

Over 1 Month [-]% Over 3 Months 0.00% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Sai Parenterals Ltd fundamentals


  • Market cap (Cr)

    1,946.10

  • P/E Ratio (TTM)

    0.00

  • Beta

    0.65

  • Book Value / share

    105.68

  • Return on equity

    12.21%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text
  • Market cap (Cr)

    1,933.10

  • P/E Ratio (TTM)

    0.00

  • Beta

    0.61

  • Book Value / share

    105.68

  • Return on equity

    12.21%

  • EPS (TTM)

    0.00

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Sai Parenterals Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 124.27
Operating Expense 110.10
Net Profit 10.34
Net Profit Margin (%) 8.32
Earnings Per Share (EPS) 3.89
EBITDA 27.18
Effective Tax Rate (%) 28.14
Particulars MAR 2024 (Values in Cr)
Revenue 113.89
Operating Expense 104.74
Net Profit 7.16
Net Profit Margin (%) 6.28
Earnings Per Share (EPS) 8.95
EBITDA 22.54
Effective Tax Rate (%) 29.80
Particulars MAR 2023 (Values in Cr)
Revenue 96.80
Operating Expense 89.75
Net Profit 4.60
Net Profit Margin (%) 4.75
Earnings Per Share (EPS) 6.46
EBITDA 17.84
Effective Tax Rate (%) 36.82
Particulars MAR 2025 (Values in Cr)
Book Value / Share 35.19
ROE % 17.18
ROCE % 16.69
Total Debt to Total Equity 1.26
EBITDA Margin 24.55
Particulars MAR 2024 (Values in Cr)
Book Value / Share 56.27
ROE % 15.88
ROCE % 16.13
Total Debt to Total Equity 1.77
EBITDA Margin 21.52
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.03
ROE % 13.91
ROCE % 12.97
Total Debt to Total Equity 2.18
EBITDA Margin 19.39
Particulars MAR 2025 (Values in Cr)
Book Value / Share 34.32
ROE % 12.21
ROCE % 13.87
Total Debt to Total Equity 0.84
EBITDA Margin 21.88
Particulars MAR 2024 (Values in Cr)
Book Value / Share 58.94
ROE % 13.07
ROCE % 13.12
Total Debt to Total Equity 1.28
EBITDA Margin 19.80
Particulars MAR 2023 (Values in Cr)
Book Value / Share 44.02
ROE % 14.61
ROCE % 12.07
Total Debt to Total Equity 2.18
EBITDA Margin 18.46
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.08
Total Assets 272.38
Total Liabilities 272.38
Total Equity 95.77
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 5.30
Return on Capital (%) 7.62
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 4.38
Total Assets 268.09
Total Liabilities 268.09
Total Equity 76.40
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 3.13
Return on Capital (%) 4.31
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 133.96
Total Liabilities 133.96
Total Equity 31.48
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.26
Return on Capital (%) 4.37
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 215.14
Total Liabilities 215.14
Total Equity 91.34
Share Outstanding 2
Price to Book Ratio 0.00
Return on Assets (%) 4.80
Return on Capital (%) 6.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.38
Total Assets 194.03
Total Liabilities 194.03
Total Equity 78.08
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 3.69
Return on Capital (%) 4.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.90
Total Assets 133.96
Total Liabilities 133.96
Total Equity 31.47
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) 3.43
Return on Capital (%) 4.6
Particulars MAR 2025 (Values in Cr)
Net Income 19.90
Cash from Operations 33.69
Cash from Investing 0.43
Cash from Financing -35.88
Net change in Cash -2.29
Free Cash Flow 33.69
Particulars MAR 2024 (Values in Cr)
Net Income 12.55
Cash from Operations -29.82
Cash from Investing -46.32
Cash from Financing 78.57
Net change in Cash 2.48
Free Cash Flow 5.24
Particulars MAR 2023 (Values in Cr)
Net Income 7.25
Cash from Operations -10.10
Cash from Investing -19.02
Cash from Financing 23.98
Net change in Cash -7.84
Free Cash Flow 5.63
Particulars MAR 2025 (Values in Cr)
Net Income 14.39
Cash from Operations 13.84
Cash from Investing -4.27
Cash from Financing -5.80
Net change in Cash -0.28
Free Cash Flow 17.85
Particulars MAR 2024 (Values in Cr)
Net Income 10.20
Cash from Operations -1.21
Cash from Investing -31.96
Cash from Financing 35.87
Net change in Cash -0.52
Free Cash Flow 1.36
Particulars MAR 2023 (Values in Cr)
Net Income 7.25
Cash from Operations -18.13
Cash from Investing -17.25
Cash from Financing 30.23
Net change in Cash -7.85
Free Cash Flow -0.79
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 28.66 12.41 1.48 219.63 23.12 41.45
BLISS GVS PHARMA LTD. 261.00 24.95 2.43 2761.09 105.05 265.00
CIPLA LTD 1211.30 20.58 2.97 97846.71 1165.55 1672.20
FERMENTA BIOTECH LIMITED 325.80 10.84 2.45 958.86 252.15 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 28.66 27.56 3.99 219.63 23.12 41.45
AMRUTANJAN HEALTH CARE LTD. 525.20 26.26 4.43 1518.39 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8718.05 104.77 27.27 21795.13 7630.00 10653.05
BLISS GVS PHARMA LTD. 261.00 35.56 2.50 2761.09 105.05 265.00

Sai Parenterals Ltd shareholding pattern

Holding

30.25%
51.15%
5.72%
12.86%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

Sai Parenterals Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
440.50 3.24 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 420.00
  • 26 Days 416.70
  • 10 Days 416.70
  • 50 Days 416.70
  • 12 Days 416.70
  • 100 Days 416.70
  • 20 Days 416.70
  • 200 Days 416.70
425.85 PIVOT

First Support

416.80

First Resistance

435.70

Second Support

406.95

Second Resistance

444.75

Third Support

397.90

Third Resistance

454.60

RSI

0.00

ADX

68.71

MACD

0.00

Williams % R

-39.29

Commodity Channel Index (CCI)

156.20

Date

2026-04-13

Week

361162.00

Same Day

420872.00

Month

345957.00

1 Year

0.66

3 Year

0.65

Over 1 Month

5.16%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Sai Parenterals Ltd Corporate Actions

Top Gainers

Sai Parenterals Ltd Share Price

Sai Parenteral's Limited was originally incorporated as Sai Parenteral's Private Limited', a Private Limited Company on January 12, 2001, with the Registrar of Companies, at Hyderabad. Thereafter, Company was converted into a Public Limited Company and the name of Company was changed to Sai Parenteral's Limited' w.e.f January 17, 2022.

Sai Parenteral's is a diversified pharmaceutical formulations company engaged in the business of Branded Generic Formulations and Contract Development and Manufacturing Organization (CDMO) products and services for the domestic and international markets. Company has developed a comprehensive and diversified portfolio of complex pharmaceutical products, covering both high-value and high-volume categories addressing critical therapeutic needs across the multiple disease areas. The key therapeutic areas include cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements (VMS), analgesics and dermatology products in dosage forms such as injectables, tablets, capsules, liquid orals and ointments.

The Company acquired Unit-I and Unit-II in 2016. It launched Prefilled technology equipment at Unit-I in FY 2021. Company has undertaken strategic acquisitions that expanded the manufacturing, technological and CDMO capabilities, diversified the product range and increased geographical presence in regulated and semi regulated markets.

In February 2022, Company acquired Unit III facility located at IDA Bhongir, Hyderabad and accredited by the Therapeutic Goods Administration (TGA), Australia. In September 2022, Company acquired Unit IV facility accredited with Pharmaceutical Inspection Co-operation Scheme (PIC/S) and WHO-GMP. It started the export business in 2023 after acquiring two internationally accredited manufacturing units in Hyderabad, Telangana. In February 2024, Company further expanded its domestic presence by making Revat Laboratories as a wholly owned subsidiary. The Company has incorporated a wholly owned subsidiary, Sai Parenterals Pte. Limited in Singapore in FY25.

Company is planning the Initial Public Offer by issuing 3,500,000 equity shares having the face value of Rs 5 each through Offer for Sale and by raising Rs 285 Cr equity shares through Fresh Issue.

Parent organization Indian Private
NSE symbol SAIPARENT
Founded 2001
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Sai Parenterals Ltd?

Answer Field

Sai Parenterals Ltd share price is for NSE ₹ 447.60 & for BSE ₹ 447.55 as on Apr 16 2026 10:17 AM.

What is the Market Cap of Sai Parenterals Ltd Share?

Answer Field

The market cap of Sai Parenterals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Apr 16 2026 10:17 AM.

What is the 52 Week High and Low of Sai Parenterals Ltd?

Answer Field

The 52 Week High and Low of Sai Parenterals Ltd for NSE is ₹ 457.45 and ₹ 400.00 and for BSE is ₹ 455.95 and ₹ 400.00.

What is 1 year return for Sai Parenterals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Sai Parenterals Ltd Share?

Answer Field

As on Apr 16 2026 10:17 AM the price-to-earnings (PE) ratio for Sai Parenterals Ltd share is 0.00.

What is the PB ratio of Sai Parenterals Ltd Share?

Answer Field

As on Apr 16 2026 10:17 AM, the price-to-book (PB) ratio for Sai Parenterals Ltd share is 105.68.

How to Buy Sai Parenterals Ltd Share?

Answer Field

You can trade in Sai Parenterals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Sai Parenterals Ltd Share on Bajaj Broking App?

Answer Field

To buy Sai Parenterals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Sai Parenterals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59